Novartis AG (NVS) analyst actions
Rating and price-target actions on NVS in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the NVS overview →
2 measured NVS analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Novartis AG (NVS) And Encourages Shareholders to Reach Out | Press release | +0.11% | +0.03% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Novartis AG (NVS) And Encourages Stockholders to Reach Out | Press release | +0.00% | -0.68% |
Keep exploring
More NVS: earnings → · SEC filings → · NVS overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| IQVIA Holdings, Inc. (IQV) | 329 | +0.02% | 51% |
| DBV Technologies S.A. - American Depositary Shares (DBVT) | 327 | -0.15% | 40% |
| Theravance Biopharma, Inc. - Ordinary Shares (TBPH) | 326 | +0.10% | 57% |
| Verona Pharma plc - American Depositary Shares (VRNA) | 325 | -0.03% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.